Fisher & Paykel Healthcare Corporation Limited (NZE:FPH)
48.18
-0.40 (-0.82%)
Nov 17, 2026, 1:30 PM NZDT
NZE:FPH Stock Forecast
Stock Price Forecast
According to 11 analysts polled by S&P Global, NZE:FPH stock has a consensus rating of "Buy" and an average price target of $46.77. The average 1-year stock price forecast is 2.93% lower than the current stock price, while the lowest is $30.50 (-36.70%) and the highest is $57.50 (+19.34%).
Price Target: $46.77 (-2.93%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for NZE:FPH stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 4 | 4 | 4 |
| Buy | 2 | 2 | 2 | 3 | 3 | 2 |
| Hold | 6 | 6 | 6 | 4 | 4 | 4 |
| Sell | 1 | 1 | 1 | 1 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 1 | 1 |
| Total | 12 | 12 | 12 | 12 | 12 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Hold Maintains $42.00 → $51.00 | Hold | Maintains | $42.00 → $51.00 | +5.85% | Nov 4, 2026 |
| Jefferies | Jefferies | Buy Maintains $52.08 → $56.06 | Buy | Maintains | $52.08 → $56.06 | +16.35% | Oct 30, 2026 |
| RBC Capital | RBC Capital | Buy Upgrades $39.00 → $52.00 | Buy | Upgrades | $39.00 → $52.00 | +7.93% | Sep 15, 2026 |
| Citi | Citi | Buy Upgrades $40.00 → $51.00 | Buy | Upgrades | $40.00 → $51.00 | +5.85% | Sep 10, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains $53.18 | Buy | Maintains | $53.18 | +10.37% | Aug 25, 2026 |
Financial Forecast
Revenue This Year
2.56B
from 2.31B
Increased by 11.07%
Revenue Next Year
2.87B
from 2.56B
Increased by 11.81%
EPS This Year
0.94
from 0.79
Increased by 19.02%
EPS Next Year
1.09
from 0.94
Increased by 15.83%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is NZD.